IRIS
DE SANCTIS, Rita
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.866
AS - Asia 1.609
SA - Sud America 831
EU - Europa 730
AF - Africa 113
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 8
Totale 6.172
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.781
SG - Singapore 871
BR - Brasile 715
CN - Cina 316
VN - Vietnam 206
FI - Finlandia 139
IT - Italia 137
IE - Irlanda 113
DE - Germania 72
NG - Nigeria 67
FR - Francia 56
CA - Canada 52
AR - Argentina 50
GB - Regno Unito 45
TR - Turchia 38
HK - Hong Kong 37
SE - Svezia 33
IN - India 30
NL - Olanda 30
EC - Ecuador 26
MX - Messico 26
RU - Federazione Russa 25
BD - Bangladesh 22
ES - Italia 16
ID - Indonesia 15
IL - Israele 15
ZA - Sudafrica 15
BE - Belgio 14
MA - Marocco 13
EU - Europa 10
IQ - Iraq 10
CO - Colombia 9
JP - Giappone 9
PY - Paraguay 9
CZ - Repubblica Ceca 7
UA - Ucraina 7
AU - Australia 6
CL - Cile 6
RO - Romania 6
VE - Venezuela 6
EG - Egitto 5
IR - Iran 5
NP - Nepal 5
PE - Perù 5
PL - Polonia 5
SA - Arabia Saudita 5
LT - Lituania 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AT - Austria 3
AZ - Azerbaigian 3
BW - Botswana 3
GR - Grecia 3
KE - Kenya 3
UY - Uruguay 3
UZ - Uzbekistan 3
AL - Albania 2
AM - Armenia 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
DZ - Algeria 2
ET - Etiopia 2
JO - Giordania 2
KZ - Kazakistan 2
MD - Moldavia 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PK - Pakistan 2
SI - Slovenia 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
EE - Estonia 1
GA - Gabon 1
GE - Georgia 1
HN - Honduras 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PT - Portogallo 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 6.172
Salva come PNG Salva come JPEG
Città #
Wilmington 467
Singapore 303
Chandler 232
The Dalles 210
San Mateo 172
Shanghai 171
Ann Arbor 166
Dallas 156
Helsinki 139
Ashburn 129
Dublin 113
Leawood 101
New York 100
Boardman 90
Lawrence 85
Princeton 85
Beijing 82
Ho Chi Minh City 76
Benin City 66
São Paulo 65
Fairfield 56
Paris 50
Woodbridge 44
Hanoi 43
Toronto 41
Hong Kong 35
Rio de Janeiro 33
Kocaeli 31
Los Angeles 27
Amsterdam 25
London 23
Milan 18
Phoenix 15
Brussels 14
Seattle 14
Curitiba 13
Brasília 12
Guayaquil 12
Monmouth Junction 12
Fortaleza 10
Munich 10
Brooklyn 9
Buenos Aires 9
Naples 9
Porto Alegre 9
Recife 9
Assago 8
Biên Hòa 8
Hải Dương 8
Tokyo 8
Chennai 7
Johannesburg 7
Mexico City 7
Montreal 7
Quito 7
Santa Clara 7
Belo Horizonte 6
Brno 6
Da Nang 6
Natal 6
Norwalk 6
Osasco 6
Pune 6
Salvador 6
San Diego 6
Abbiategrasso 5
Atlanta 5
Cachoeirinha 5
Campinas 5
Casablanca 5
Dhaka 5
Franca 5
Haiphong 5
Ribeirão Preto 5
Sorocaba 5
São Bernardo do Campo 5
Uberlândia 5
Asunción 4
Baghdad 4
Bauru 4
Bergamo 4
Cuiabá 4
Foz do Iguaçu 4
Goiânia 4
Guarulhos 4
Ha Long 4
Irecê 4
Joinville 4
Laferrere 4
Lima 4
Lấp Vò 4
Manaus 4
Maringá 4
Moscow 4
Nova Iguaçu 4
Suzano 4
Venice 4
Vitória da Conquista 4
Aparecida de Goiânia 3
Araras 3
Totale 3.869
Salva come PNG Salva come JPEG
Nome #
Biological characteristics and long-term outcomes in node-negative breast cancer 104
Palonosetron plus three-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy 104
Perfusion Computed Tomography as prognostic and predictive factor in patients with colorectal cancer liver metastases treated with bevacizumab 94
Treatment of malignant pleural mesothelioma: current status and future directions 94
Imatinib mesylate in desmoplastic small round cell tumour 92
Neutrophil to Lymphocyte Ratio (NLR) as predictive factor in patients with metastatic soft tissue sarcoma (STS) treated with trabectedin (T). 91
Survival outcome and prognostic factors after pulmonary metastasectomy in sarcoma patients 89
Superiority of CHOI vs RECIST criteria in evaluating outcome of advanced soft tissue sarcoma (STS) patients treated with sorafenib 87
Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy 87
Safety and efficacy of oral combination of vinorelbine and capecitabine in metastatic breast cancer 87
A monocentric retrospective analysis of TILs and AR as hints for prognosis definition in TNBC 87
PERFUSION COMPUTED TOMOGRAPHY AS PROGNOSTIC AND PREDICTIVE FACTOR IN PATIENTS WITH COLORECTAL CANCER LIVER METASTASES TREATED WITH BEVACIZUMAB 86
Safety and efficacy of oral vinorelbine and capecitabine combination for metastatic breast cancer 83
Zoledronic acid (ZA) and treatment of bone metastasis in patients with advanced lung cancer (NSCLC and SCLC). 76
Colorectal cancer liver metastases treated with target therapies: monitoring response with constrat-enhanced ultrasonography (CE-US). 76
Phase II study: Docetaxel-cisplatin and pro drug tegafur (TPF) as neoadjuvant treatment in advanced patients with head and neck cancer (HNC): Results and correlation between tandem magnesium/creatinine and toxicity 75
Carcinoma gastrico metastatico e Docetaxel, Cisplatino, Fluorouracile (DCF) settimanale: tolleranza e risposta 73
Phase I pharmacokinetic and pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors 73
Atypical Lipomatous Tumors: Should They be Treated Like Other Sarcoma or Not? Surgical Consideration from a Bi-Institutional Experience 72
Response to Sunitinib in an Adult Patient With Rhabdoid Renal Cell Carcinoma 71
Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma. 70
48P The relationship among bowel FDG-PET uptake, pathological complete response, and the influence of eating and exercise habits in breast cancer patients undergoing neoadjuvant chemotherapy 69
Phase II prospective study with sorafenib in advanced soft tissue sarcomas after anthracycline-based therapy 68
Colorectal cancer liver metastases treated with target therapies: monitoring response with contrast-enhanced ultrasonography (CE-US). 68
wALT trial (Phase I-II): weekly non-pegylated liposomal anthracycline and taxane combination in first line breast cancer chemotherapy 67
Early response evaluation of antiangiogenic therapy: use of contrast-enhanced ultrasonography (CE-US) in hepatocellular carcinoma 66
Docetaxel in combination with gemcitabine as second line treatment in patients with platinum resistant advanced NSCLC 66
Capecitabine in elderly patients with metastatic breast cancer 66
Clinical predictors of cardiac toxicity in HER2-positive early breast cancer patients treated with adjuvant s.c. versus i.v. trastuzumab 66
PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy 65
Activity of regorafenib in advanced pretreated soft tissue sarcoma: Results of a single-center phase II study 65
First-line chemotherapy in over-70 patients with colon cancer. 64
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial 64
High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial 63
WALT TRIAL (PHASE III): WEEKLY NON PEGYLATED LIPOSOMAL ANTHRACYCLINE AND TAXANE COMBINATION IN FIRSTLINE BREAST CANCER CHEMOTHERAPY 63
Dietary chemoprevention of colorectal cancer 62
A Study of Clinical Features and Risk Factors of Self-Referring Emergency Department Headache Patients: A Comparison with Headache Center Outpatients 61
Efficacy and tolerability of a single-day three drugs combination of aprepitant, palonosetron and dexamethasone in patients receiving moderately emetogenic chemotherapy 61
Descripcion de un sistema de realidad virtual dirigido a la promocion de bienestar emocional en pazientes oncologicoa hospidalizados: ensayo fase II OncoHelp 58
Capecitabine in elderly breast cancer patients 58
Never too old to fight breast cancer 57
Safety and efficacy of bevacizumab with first-line FOLFIRI for metastatic colorectal cancer: single center experience 57
Vinorelbine in pemetrexed-pretreated patients with malignant pleural mesothelioma 57
Predictive Factors of Eribulin Activity in Metastatic Breast Cancer Patients 56
Bevacizumab in combination with FOLFIRI as first-line treatment for metastatic colorectal cancer: outcomes from a single center experience 56
Unsupervised versus Supervised Identification of Prognostic Factors in Patients with Localized Retroperitoneal Sarcoma: A Data Clustering and Mahalanobis Distance Approach 55
Prognostic factors and outcome of HER2+ breast cancer with CNS metastases 55
SAFETY AND EFFICACY OF SORAFENIB FOR ADVANCED HEPATOCELLULAR CARCINOMA 54
Phase I, pharmacokinetics, pharmacodynamic study of lapatinib in combination with sorafenib in patients with advanced refractory solid tumors 54
Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group 54
HER2-positive breast cancer and CNS metastases: Prognostic factors and clinical outcome 53
Long-term Follow-up and Post-relapse Outcome of Patients with Localized Retroperitoneal Sarcoma Treated in the Italian Sarcoma Group-Soft Tissue Sarcoma (ISG-STS) Protocol 0303 53
Feasibility of preoperative chemotherapy with or without radiation therapy in localized soft tissue sarcomas of limbs and superficial trunk in the Italian sarcoma group/grupo español de investigación en sarcomas randomized clinical trial: Three versus five cycles of full-dose epirubicin plus ifosfamide 53
Platinum salts in the treatment of BRCA-associated breast cancer: A true targeted chemotherapy? 52
SAFETY AND EFFICACY OF ORAL COMBINATION CHEMOTHERAPY IN METASTATIC BREAST CANCER: VINORELBINE AND CAPECITABINE 52
Primary breast leiomyosarcoma and synchronous homolateral lung cancer: a case report 52
Juxtaglomerular cell tumor: Multicentric synchronous disease associated with paraneoplastic syndrome 52
Role of Surgery in the Multimodal Treatment of Primary and Recurrent Leiomyosarcoma of the Inferior Vena Cava 52
The therapeutic potential of duloxetine in prostate cancer-related fatigue 51
Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: A phase I-II study from the Italian Sarcoma Group 51
Trabectedin for the treatment of soft tissues sarcomas 50
Non-pegylated liposomal doxorubicin plus ifosfamide in metastatic soft tissue sarcoma: results from a phase-II trial 50
Efficacy of trabectedin in advanced soft tissue sarcoma: Beyond lipo- and leiomyosarcoma 50
Trabectedin for the treatment of soft tissue sarcoma 48
A pilot analysis of headache disorders in breast cancer patients 48
Pulmonary sarcomatoid carcinoma presenting both ALK rearrangement and PD-L1 high positivity: A case report on the therapeutic regimen 47
Phase I, pharmacokinetic (PK), pharmacodynamic (PD) study of lapatinib (L) in combination with sorafenib (S) in patients with advanced refractory solid tumors 47
Temporal–occipital glioblastoma presenting with Alice in Wonderland Syndrome in a patient with a long-time history of migraine without aura 47
A systematic review of systematic reviews and pooled meta-analysis on pharmacological interventions to improve cancer-related fatigue 47
TNBC universe: A monocentric retrospective analyses of TILs and AR as prognostic markers 46
Primary ovarian insufficiency associated with pazopanib therapy in a breast angiosarcoma patient: A CARE-compliant case report 46
Clinical Review on the Management of Breast Cancer Visceral Crisis 45
A Propensity Score Matching Study on the Effect of OnabotulinumtoxinA Alone versus Short-Term Psychodynamic Psychotherapy Plus Drug-of-Choice as Preventive Therapy in Chronic Migraine: Effects and Predictive Factors 45
Imatinib mesylate in desmoplastic small round cell tumors 45
Palonosetron plus three-day aprepitant and dexamethasone schedule to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy 45
Fulvestrant and trastuzumab in patients with luminal HER2-positive advanced breast cancer (ABC): an Italian real-world experience (HERMIONE 9) 45
Safety, tolerability and early response evaluation of sarafenib in hepatocellular carcinoma in erderly: use of contrast-enhanced ultrasonography (CE-US). 44
Opportunities and Challenges of Synthetic Data Generation in Oncology 43
Never too old to fight breast cancer: A case report 43
Heterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targets 42
Oral vinorelbine in elderly or unfit patients with metastatic NSCLC 42
Sporadic desmoid tumors of the abdominal wall: the results of surgery 41
Insights for the application of TILs and AR in the treatment of TNBC in routine clinical practice 41
Commentary: Improvement in diagnostic-therapeutic care pathways for women with migraine: an Italian Delphi panel 41
From seaside to bedside: Current evidence and future perspectives in the treatment of breast cancer using marine compounds 40
Phase I, Pharmacokinetics (PK), Pharmacodynamic (PD) Study of Lapatinib (L) in Combination With Sorafenib (S) in Patients With Advanced Refractory Solid Tumours 40
Common Misconceptions about Diet and Breast Cancer: An Unclear Issue to Dispel 39
The role of docetaxel in the multimodal treatment of non-small cell lung cancer 39
[Integrated treatment of breast cancer: review of our experience] 38
Re: Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patients: Sympathetic nervous system activity on breast cancer: the story of migraine 38
Imaging Correlates between Headache and Breast Cancer: An [18F]FDG PET Study 38
A Prognostic Model Based on Residual Cancer Burden and Tumor-Infiltrating Lymphocytes on Residual Disease after Neoadjuvant Therapy in HER2+ Breast Cancer 36
[The clinical significance of lymph node micrometastases and of concept of sentinel lymph node] 35
Safety, Tollerability and Early Response Evaluation of Sorafenib In Hepatocellular Carcinoma In Elderly: Use of Contrast-enhanced Ultrasonography (ce-us) 35
The Role of Female Reproductive Hormones in the Association between Migraine and Breast Cancer: An Unanswered Question 34
Volumetric-modulated-arc-therapy versus 3D-conformal-radiotherapy for sarcoma of extremities 33
Defining T cell dysfunctionality in breast cancer by single cell analysis: Implications for immunotherapy 33
Charting the Course in Sequencing Antibody-Drug Conjugates in Breast Cancer 32
Neoadjuvant chemotherapy in hormone receptor-positive/HER2-negative early breast cancer: when, why and what? 32
Prevalence of treatment-related adverse events (TRAEs) with antibody-drug conjugates in metastatic breast cancer patients: A systematic review and meta-analysis 32
Totale 5.729
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.406
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.406
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021949 0 0 0 0 0 287 158 50 245 108 4 97
2021/2022445 32 2 15 79 14 7 12 64 44 77 89 10
2022/2023898 182 19 114 58 79 46 4 72 137 97 78 12
2023/2024779 54 63 164 34 30 110 52 32 8 21 67 144
2024/20251.215 27 3 4 11 15 173 51 118 216 276 151 170
2025/20261.947 486 621 236 419 154 31 0 0 0 0 0 0
Totale 6.315